drugset / Trial / NCT00194480
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users
Phase 4
Completed
21 enrolled
National Institute on Drug Abuse (NIDA)
University of Washington · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Injection drug use accounts for transmission of a high proportion of Hepatitis C Virus (HCV) infections. The purpose of this trial is to investigate the effectiveness of pegylated interferon in treating injection drug users (IDUs) with acute HCV.
Timeline
- Start
- 2003-04
- Primary completion
- 2006-12
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peginterferon alfa-2a | Protein / enzyme biologic | — | Other |